AU544792B2 - Monoclonal antibodies to human helper t cells - Google Patents
Monoclonal antibodies to human helper t cellsInfo
- Publication number
- AU544792B2 AU544792B2 AU57758/80A AU5775880A AU544792B2 AU 544792 B2 AU544792 B2 AU 544792B2 AU 57758/80 A AU57758/80 A AU 57758/80A AU 5775880 A AU5775880 A AU 5775880A AU 544792 B2 AU544792 B2 AU 544792B2
- Authority
- AU
- Australia
- Prior art keywords
- cells
- monoclonal antibodies
- human helper
- sub
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3061—Blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/966—Chemistry: molecular biology and microbiology involving an enzyme system with high turnover rate or complement magnified assay, e.g. multi-enzyme systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
Abstract
Hybrid cell line for production of monoclonal antibody to an antigen found on all normal human helper T cells. The hybrid is formed by fusing splenocytes from immunized CAF<sub>1</sub> mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US033639 | 1979-04-26 | ||
US06/033,639 US4381295A (en) | 1979-04-26 | 1979-04-26 | Monoclonal antibody to human helper T cells and methods of preparing same |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5775880A AU5775880A (en) | 1980-10-30 |
AU544792B2 true AU544792B2 (en) | 1985-06-13 |
Family
ID=21871570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU57758/80A Expired AU544792B2 (en) | 1979-04-26 | 1980-04-24 | Monoclonal antibodies to human helper t cells |
Country Status (22)
Country | Link |
---|---|
US (1) | US4381295A (en) |
EP (1) | EP0018794B1 (en) |
JP (2) | JPS55145616A (en) |
AT (1) | ATE14454T1 (en) |
AU (1) | AU544792B2 (en) |
CA (1) | CA1170592A (en) |
DE (2) | DE3070896D1 (en) |
DK (1) | DK154087C (en) |
ES (1) | ES490943A0 (en) |
FI (1) | FI75363C (en) |
GR (1) | GR67298B (en) |
HK (1) | HK23786A (en) |
IE (1) | IE50459B1 (en) |
IL (1) | IL59919A (en) |
MY (1) | MY8600513A (en) |
NO (1) | NO159883C (en) |
NZ (1) | NZ193470A (en) |
PH (1) | PH16656A (en) |
PT (1) | PT71148B (en) |
SG (1) | SG6586G (en) |
YU (1) | YU44957B (en) |
ZA (1) | ZA802524B (en) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4381292A (en) * | 1980-11-14 | 1983-04-26 | The Board Of Trustees Of The Leland Stanford Jr. University | Anti-human T-lymphocyte monoclonal antibody |
US4824432A (en) * | 1981-03-24 | 1989-04-25 | S.V.S. Laboratories, Inc. | Method for treating AIDS and other immune deficiencies and immune disorders |
US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
USRE32011E (en) * | 1981-12-14 | 1985-10-22 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
US4511662A (en) * | 1982-06-18 | 1985-04-16 | Bio-Rad Laboratories, Inc. | Simultaneous assay for T and B lymphocyte populations and subpopulations |
US4443427A (en) * | 1982-06-21 | 1984-04-17 | Sidney Farber Cancer Institute, Inc. | Monoclonal antibody |
US4582790A (en) * | 1983-02-15 | 1986-04-15 | Wisconsin Alumni Research Foundation | Monoclonal antibody to angiotension-converting enzyme and methods of preparing and using same |
US4550086A (en) * | 1983-02-16 | 1985-10-29 | Dana-Farber Cancer Institute, Inc. | Monoclonal antibodies that recognize human T cells |
US4677056A (en) * | 1983-08-18 | 1987-06-30 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibody subsetting human helper and killer T-cells and method |
USRE35277E (en) * | 1983-09-11 | 1996-06-18 | Yeda Research And Development Co. Ltd. | Cell membrane proteins, compositions containing them and procedure for their preparation |
IL69686A (en) * | 1983-09-11 | 1988-03-31 | Yeda Res & Dev | Compositions containing cell membrane proteins and process for their preparation |
US4645738A (en) * | 1983-09-30 | 1987-02-24 | Memorial Sloan-Kettering Institute Cancer Center | Method for differential diagnosis of T cell leukemias using monoclonal antibodies |
JPS60231699A (en) * | 1983-11-09 | 1985-11-18 | Aichiken | Novel monoclonal antibody |
US4469630A (en) * | 1983-11-25 | 1984-09-04 | J. T. Baker Chemical Co. | Purification of monoclonal antibodies |
DE3482649D1 (en) | 1983-12-16 | 1990-08-09 | Denis M Callewaert | JOB SELECTIVE PLASMINOGEN ACTIVATOR AND METHOD FOR THE PRODUCTION AND USE THEREOF. |
US5130144B1 (en) * | 1984-02-06 | 1995-08-15 | Univ Johns Hopkins | Human stem cells and monoclonal antibodies |
US4965204A (en) * | 1984-02-06 | 1990-10-23 | The Johns Hopkins University | Human stem cells and monoclonal antibodies |
US4604235A (en) * | 1984-05-23 | 1986-08-05 | J. T. Baker Chemical Company | Purification of monoclonal antibodies |
ATE64855T1 (en) * | 1984-09-14 | 1991-07-15 | Pasteur Institut | PREPARATIONS AND METHODS FOR THE PROTECTION OF TLYMPHOCYTES AGAINST THE DISEASE AGENT OF LYMPHADENOPATHY AND ACQUIRED IMMUNE DEPRESSION SYNDROME. |
FR2570278B1 (en) * | 1984-09-14 | 1987-02-13 | Pasteur Institut | COMPOSITIONS AND METHOD FOR PROTECTING T CELLS FROM THE ETIOLOGICAL AGENT OF LYMPHADENOPATHIES AND ACQUIRED IMMUNODEPRESSION SYNDROME |
US4695459A (en) * | 1984-12-26 | 1987-09-22 | The Board Of Trustees Of Leland Stanford Junior University | Method of treating autoimmune diseases that are mediated by Leu3/CD4 phenotype T cells |
US4661446A (en) * | 1985-02-19 | 1987-04-28 | Dana-Farber Cancer Institute, Inc. | Monoclonal antibodies and method of immunizing therewith |
US5776093A (en) * | 1985-07-05 | 1998-07-07 | Immunomedics, Inc. | Method for imaging and treating organs and tissues |
DE3541033A1 (en) * | 1985-11-19 | 1987-05-21 | Boehringer Mannheim Gmbh | METHOD FOR QUANTIFYING CELL POPULATIONS OR SUBPOPULATIONS AND REAGENT SUITABLE FOR THIS |
GB8608068D0 (en) * | 1986-04-02 | 1986-05-08 | Cobbold S P | Monoclonal antibodies |
CA1296622C (en) * | 1986-08-12 | 1992-03-03 | Jeffrey E. Anderson | Method and apparatus for automated assessment of the immunoregulatory status of the mononuclear leukocyte immune system |
US5601819A (en) * | 1988-08-11 | 1997-02-11 | The General Hospital Corporation | Bispecific antibodies for selective immune regulation and for selective immune cell binding |
US5068178A (en) * | 1988-12-06 | 1991-11-26 | Genetic Systems Corporation | Method of enhancing direct immunofluorescence staining of cells |
US7037496B2 (en) * | 1989-12-27 | 2006-05-02 | Centocor, Inc. | Chimeric immunoglobulin for CD4 receptors |
JPH0424999U (en) * | 1990-06-26 | 1992-02-28 | ||
GB9021677D0 (en) * | 1990-10-05 | 1990-11-21 | Xaar Ltd | Method of testing multi-channel array pulsed droplet deposition apparatus |
JPH05505112A (en) * | 1990-11-27 | 1993-08-05 | バイオジェン,インコーポレイテッド | Anti-CD4 antibody homologues useful in the prevention and treatment of AIDS, ARC and HIV infections |
US5747265A (en) * | 1992-10-30 | 1998-05-05 | T Cell Diagnostics, Inc. | Method for measuring the amount of a cell-associated molecule |
EP0703925B1 (en) * | 1993-06-03 | 1999-08-18 | Therapeutic Antibodies Inc. | Production of antibody fragments |
US5961976A (en) * | 1996-06-03 | 1999-10-05 | United Biomedical, Inc. | Antibodies against a host cell antigen complex for pre- and post-exposure protection from infection by HIV |
JP2001500369A (en) | 1996-08-30 | 2001-01-16 | ヒューマン ジノーム サイエンシーズ,インコーポレイテッド | Interleukin-19 |
EP1034003A4 (en) | 1997-11-24 | 2004-07-14 | Johnson T Wong | Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy |
US6790796B2 (en) | 2001-10-05 | 2004-09-14 | Albany International Corp. | Nonwovens forming or conveying fabrics with enhanced surface roughness and texture |
US20080279848A1 (en) * | 2006-03-16 | 2008-11-13 | Genentech, Inc. | Methods of treating lupus using CD4 antibodies |
AU2007227609A1 (en) * | 2006-03-16 | 2007-09-27 | Genentech, Inc. | Methods of treating lupus using CD4 antibodies |
TW201016233A (en) * | 2008-07-15 | 2010-05-01 | Genentech Inc | Methods of treating autoimmune diseases using CD4 antibodies |
BR112017005134A2 (en) | 2014-09-16 | 2017-12-12 | Ubi Ip Holdings | treatment and functional cure of monoclonal antibody hiv infection for cd-mediated competitive hiv entry inhibition |
SG10202100268RA (en) | 2016-08-13 | 2021-02-25 | United Biopharma Inc | Treatment and sustained virologic remission of hiv infection by antibodies to cd4 in haart stabilized patients |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4196265A (en) * | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
-
1979
- 1979-04-26 US US06/033,639 patent/US4381295A/en not_active Expired - Lifetime
-
1980
- 1980-04-01 CA CA000348981A patent/CA1170592A/en not_active Expired
- 1980-04-11 GR GR61667A patent/GR67298B/el unknown
- 1980-04-17 NZ NZ193470A patent/NZ193470A/en unknown
- 1980-04-24 PH PH23948A patent/PH16656A/en unknown
- 1980-04-24 JP JP5369080A patent/JPS55145616A/en active Granted
- 1980-04-24 AU AU57758/80A patent/AU544792B2/en not_active Expired
- 1980-04-24 PT PT71148A patent/PT71148B/en active IP Right Revival
- 1980-04-24 IL IL59919A patent/IL59919A/en unknown
- 1980-04-25 FI FI801343A patent/FI75363C/en not_active IP Right Cessation
- 1980-04-25 YU YU1148/80A patent/YU44957B/en unknown
- 1980-04-25 ES ES490943A patent/ES490943A0/en active Granted
- 1980-04-25 DE DE8080301356T patent/DE3070896D1/en not_active Expired
- 1980-04-25 IE IE839/80A patent/IE50459B1/en not_active IP Right Cessation
- 1980-04-25 DK DK180580A patent/DK154087C/en active
- 1980-04-25 EP EP80301356A patent/EP0018794B1/en not_active Expired
- 1980-04-25 ZA ZA00802524A patent/ZA802524B/en unknown
- 1980-04-25 AT AT80301356T patent/ATE14454T1/en not_active IP Right Cessation
- 1980-04-25 NO NO801216A patent/NO159883C/en unknown
- 1980-04-25 DE DE198080301356T patent/DE18794T1/en active Pending
-
1986
- 1986-01-21 SG SG65/86A patent/SG6586G/en unknown
- 1986-04-03 HK HK237/86A patent/HK23786A/en unknown
- 1986-12-30 MY MY513/86A patent/MY8600513A/en unknown
-
1988
- 1988-04-26 JP JP63101497A patent/JPH0198477A/en active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU544792B2 (en) | Monoclonal antibodies to human helper t cells | |
AU545223B2 (en) | Hybrid cell line for producing monoclonal antibody | |
AU545225B2 (en) | Hybrid cell line | |
AU545182B2 (en) | Hybrid cell hire for producing monoclonal antibody | |
AU545181B2 (en) | Hybridoma for producing monoclonal antibodies | |
AU545222B2 (en) | Hybridoma for producing monoconal antibodies |